1887
Volume 2009, Issue 1
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

To evaluate the response rate of hyperthyroidism to radioactive iodine treatment (RAI) and the mortality rate post RAI treatment in a Qatari cohort the records were analyzed retrospectively of 113 hyperthyroid Qatari patients (23 male, 90 female) treated with RAI (1-131) in the Endocrine Clinic, Hamad Medical Corporation, between 1984 and2002. 90 (79.6 %) had diffuse goiter, 14 (12.4%) multinodular goiter, 6 (5.3%) single nodular goiter and 3 (2.7 %) unknown etiology. Follow up ranged from two to ten years with free thyroxin and thyroid stimulating hormone being recorded at diagnosis; six months and one year post RAI treatment and yearly thereafter.

The incidence of hypothyroidism was 64.4% after six months post RAI treatment and 75.9% at one year. Euthyroid state was high in patients who did not receive antithyroid drugs, whereas the hypothyroid state was higher in a group with pre-treatment antithyroid medication (80% versus 62.8%). The euthyroid state was more in diffuse hyperthyroidism 22.4%, while 84.6% of multinodular goiter became hypothyroid after six months of RAI treatment. Mortality rate was not increased post RAI treatment as compared to general population.

Conclusion: The incidence of hypothyroidism was 75.9% at one-year post RAI treatment and the rate of hypothyroidism increased with the length of follow up to 10 years (86.7%). There was no linear relation in response rate to increasing doses of RAI treatment groups.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2009.1.14
2009-05-01
2020-07-08
Loading full text...

Full text loading...

References

  1. Ghadban K, Mahmoud A. Zirie, Radioiodine treatment of hyperthyroidism: success rate and influence of thyrostatic medication. Saudi Med J. 2003; 24:4:347351.
    [Google Scholar]
  2. Judith E. Kalinyak, Rose McDougall. Editorial: How Should the Dose ofIodine-131 Be Determined in the Treatment of Graves’ Hyperthyroidism? The Journal of Clinical Endocrinology and Metabolism. 2003; 88:3:975977.
    [Google Scholar]
  3. William D, Leslie Linda Ward. A Randomized Comparison of Radioiodine Doses in Graves’ Hyperthyroidism. The Journal of Clinical Endocrinology and Metabolism. 2003; 88:3:978983.
    [Google Scholar]
  4. Vania A. Andrade, Jorge L. Gross. The Effect of Methimazole Pretreatment on the Efficacy of Radioactive Iodine Therapy in Graves Hyperthyroidism: One- Year Follow-Up of a Prospective, Randomized Study. The Journal of Clinical Endocrinology and Metabolism. 2001; 86:8:34883493.
    [Google Scholar]
  5. Amit Allahabadia, Jacquie Day kin. Radioiodine Treatment of Hyp erthyroidism-Prognostic Factors for Outcome. The Journal of Clinical Endocrinology and Metabolism. 2001; 86:8:36113617.
    [Google Scholar]
  6. Franklyn JA, Maisonneuve P. Mortality After The Treatment of Hyperthyroidism with Radioactive Iodine. The New England Journal of Medicine. 1998; 338::712718.
    [Google Scholar]
  7. Lowdell CP, Dobbs HJ. Low-dose 1131 in Treatment of Graves’ Disease. Journal of the Royal Sociaty of Medicine. 1985 March; 78::197202.
    [Google Scholar]
  8. Sankar R, Sekhri T. Radioactive iodine therapy in Graves’ hyperthyroidism: a prospective study from a tertiary referral centre in north India. J Assoc Physicians India. 2005 Jul; 53::603606.
    [Google Scholar]
  9. Aftab M Ahmad, Munir Ahmad. Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis. European Journal of Endocrinology. 2002; 146::767775.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2009.1.14
Loading
  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error